- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5 +/− leukemia ; volume:15 ; number:1 ; day:13 ; month:8 ; year:2015 ; pages:1-6 ; date:12.2015
BMC cancer ; 15, Heft 1 (13.8.2015), 1-6, 12.2015
- Urheber
-
van der Weyden, Louise
- Beteiligte Personen und Organisationen
-
Giotopoulos, George
Wong, Kim
Rust, Alistair G.
Robles-Espinoza, Carla Daniela
Osaki, Hikari
Huntly, Brian J.
Adams, David J.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1586-1
- URN
-
urn:nbn:de:1111-2016110620408
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- van der Weyden, Louise
- Giotopoulos, George
- Wong, Kim
- Rust, Alistair G.
- Robles-Espinoza, Carla Daniela
- Osaki, Hikari
- Huntly, Brian J.
- Adams, David J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
RUNX1 mutations in acute myeloid leukemia
P335: Genomic determinants of therapy response in ETV6-RUNX1 leukemia
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
Somatic evolutionary timings of driver mutations
Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
RUNX1 gene expression in Egyptian acute myeloid leukemia patients: may it have therapeutic implications?
miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol
RUNX1 mutations in acute myeloid leukemia
P335: Genomic determinants of therapy response in ETV6-RUNX1 leukemia
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
Somatic evolutionary timings of driver mutations
Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
RUNX1 gene expression in Egyptian acute myeloid leukemia patients: may it have therapeutic implications?
miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol
RUNX1 mutations in acute myeloid leukemia
P335: Genomic determinants of therapy response in ETV6-RUNX1 leukemia
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
Somatic evolutionary timings of driver mutations
Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
RUNX1 gene expression in Egyptian acute myeloid leukemia patients: may it have therapeutic implications?
miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia